Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jan-Dec:21:15330338221124696.
doi: 10.1177/15330338221124696.

Current Status and Prospects of Clinical Treatment of Osteosarcoma

Affiliations
Review

Current Status and Prospects of Clinical Treatment of Osteosarcoma

Zong-Yuan Jiang et al. Technol Cancer Res Treat. 2022 Jan-Dec.

Abstract

Osteosarcoma, one of the common malignant tumors in the skeletal system, originates in mesenchymal tissue, and the most susceptible area of occurrence is the metaphysis with its abundant blood supply. Tumors are characterized by highly malignant spindle stromal cells that can produce bone-like tissue. Most of the osteosarcoma are primary, and a few are secondary. Osteosarcoma occurs primarily in children and adolescents undergoing vigorous bone growth and development. Most cases involve rapid tumor development and early blood metastasis. In recent years, research has grown in the areas of molecular biology, imaging medicine, biological materials, applied anatomy, surgical techniques, biomechanics, and comprehensive treatment of tumors. With developments in molecular biology and tissue bioengineering, treatment methods have also made great progress, especially in comprehensive limb salvage treatment, which significantly enhances the quality of life after surgery and improves the 5-year survival rate of patients with malignant tumors. This article provides a review of limb salvage, immunotherapy, gene therapy, and targeted therapy from traditional amputation to neoadjuvant chemotherapy, providing a reference for current clinical treatments for osteosarcoma.

Keywords: chemotherapy; immunotherapy; osteosarcoma; prognosis; treatment.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Common bone lesions according to age and location in the upper limb. The incidence of different bone lesions varies at different sites within the upper limb and age.
Figure 2.
Figure 2.
Clinical workflow of computer-assisted tumor surgery. In the surgical treatment of osteosarcoma, multimode image data are obtained using advanced imaging equipment. The computer processes the medical image data and aids in displaying and positioning the anatomical structure of the bones, planning the surgical path, formulating a reasonable and quantitative surgical scheme, conducting the preoperative surgical simulation, and using robot-assisted accurate guidance during surgery. With monitoring and improved accuracy of positioning, this technique can reduce surgical injury and improve the success rate of complex surgical operations.

References

    1. Zhu S, Liu Y, Wang X, et al.. lncRNA SNHG10 promotes the proliferation and invasion of osteosarcoma via Wnt/β-Catenin signaling. Mol Ther Nucleic Acids. 2020;22:957-970. - PMC - PubMed
    1. Zheng D, Liu W, Xie W, et al.. AHA1 upregulates IDH1 and metabolic activity to promote growth and metastasis and predicts prognosis in osteosarcoma. Signal Transduct Target Ther. 2021;6(1):25. - PMC - PubMed
    1. Liang X, Wang X, He Y, et al.. Acetylation dependent functions of Rab22a-NeoF1 fusion protein in osteosarcoma. Theranostics . 2020;10(17):7747-7757. - PMC - PubMed
    1. Du M, Gu J, Liu C, et al.. Genome-wide CRISPR screen identified Rad18 as a determinant of doxorubicin sensitivity in osteosarcoma. J Exp Clin Cancer Res. 2022;41(1):154. - PMC - PubMed
    1. Zalacain M, Bunuales M, Marrodan L, et al.. Local administration of IL-12 with an HC vector results in local and metastatic tumor control in pediatric osteosarcoma. Mol Ther Oncolytics. 2020;20:23-33. - PMC - PubMed

Publication types

Substances